First Horizon Advisors’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.82K | Sell |
146
-33
| -18% | -$1.09K | ﹤0.01% | 1853 |
|
|
2025
Q1 | $7.19K | Sell |
179
-153
| -46% | -$6.15K | ﹤0.01% | 1716 |
|
|
2024
Q4 | $15.6K | Buy |
332
+153
| +85% | +$7.2K | ﹤0.01% | 1428 |
|
|
2024
Q3 | $9.45K | Hold |
179
| – | – | ﹤0.01% | 1622 |
|
|
2024
Q2 | $9.7K | Hold |
179
| – | – | ﹤0.01% | 1549 |
|
|
2024
Q1 | $12.5K | Sell |
179
-13
| -7% | -$911 | ﹤0.01% | 1508 |
|
|
2023
Q4 | $16K | Buy |
192
+12
| +7% | +$1K | ﹤0.01% | 1410 |
|
|
2023
Q3 | $5.3K | Sell |
180
-15
| -8% | -$442 | ﹤0.01% | 1739 |
|
|
2023
Q2 | $6.36K | Hold |
195
| – | – | ﹤0.01% | 1716 |
|
|
2023
Q1 | $6.86K | Hold |
195
| – | – | ﹤0.01% | 1706 |
|
|
2022
Q4 | $8.93K | Sell |
195
-21
| -10% | -$962 | ﹤0.01% | 1605 |
|
|
2022
Q3 | $11K | Buy |
216
+41
| +23% | +$2.09K | ﹤0.01% | 1471 |
|
|
2022
Q2 | $6K | Buy |
175
+48
| +38% | +$1.65K | ﹤0.01% | 1754 |
|
|
2022
Q1 | $4K | Sell |
127
-48
| -27% | -$1.51K | ﹤0.01% | 1329 |
|
|
2021
Q4 | $8K | Hold |
175
| – | – | ﹤0.01% | 1590 |
|
|
2021
Q3 | $5K | Buy |
175
+127
| +265% | +$3.63K | ﹤0.01% | 1739 |
|
|
2021
Q2 | $0 | Buy |
48
+21
| +78% | – | ﹤0.01% | 1995 |
|
|
2021
Q1 | $0 | Buy |
+27
| New | – | ﹤0.01% | 1908 |
|
|
2014
Q1 | – | Sell |
-2
| Closed | – | – | 1397 |
|
|
2013
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 1340 |
|